Galectin Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $29k | 17k | 1.66 |
| 2023-09-30 | $33k | 17k | 1.92 |
| 2023-06-30 | $25k | 17k | 1.44 |
| 2023-03-31 | $37k | 17k | 2.10 |
| 2022-12-31 | $20k | 17k | 1.13 |
| 2022-09-30 | $29k | 17k | 1.67 |
| 2022-06-30 | $23k | 17k | 1.32 |
| 2022-03-31 | $29k | 17k | 1.67 |
| 2021-12-31 | $37k | 17k | 2.12 |
| 2021-09-30 | $68k | 17k | 3.91 |
| 2021-06-30 | $56k | 17k | 3.22 |
| 2021-03-31 | $169k | 78k | 2.18 |
| 2020-12-31 | $192k | 86k | 2.25 |
| 2020-09-30 | $229k | 86k | 2.68 |
| 2020-06-30 | $285k | 93k | 3.07 |
| 2020-03-31 | $182k | 92k | 1.97 |
| 2019-12-31 | $265k | 92k | 2.87 |
| 2019-09-30 | $340k | 92k | 3.68 |
| 2019-06-30 | $312k | 75k | 4.15 |
| 2018-03-31 | $102k | 21k | 4.77 |
| 2017-12-31 | $72k | 21k | 3.36 |
| 2017-09-30 | $46k | 21k | 2.15 |
| 2017-06-30 | $53k | 21k | 2.48 |
| 2017-03-31 | $350k | 152k | 2.30 |
| 2015-03-31 | $89k | 26k | 3.37 |
| 2014-12-31 | $92k | 26k | 3.48 |
| 2014-09-30 | $133k | 26k | 5.04 |
| 2014-06-30 | $365k | 26k | 13.83 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management